2025-12-28 - Analysis Report
Okay, here's a breakdown of the Procter & Gamble (PG) analysis, incorporating all the data points you provided:

**1) Return Rate Comparison:**

*   **Ticker:** PG (Procter & Gamble Co) -  A multinational consumer goods corporation.
*   **PG Cumulative Return:** 26.38%
*   **S&P 500 (VOO) Cumulative Return:** 103.21%
*   **Divergence:** -74.8 (Relative Divergence: 5.3)
*   **Analysis:** PG has significantly underperformed the S&P 500 over the period analyzed. The divergence is substantial (-74.8%), and the relative divergence of 5.3 indicates PG's underperformance is near the lower end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year      | CAGR   | MDD    | Alpha  | Beta  | Cap(B) |
| --------- | ------ | ------ | ------ | ----- | ------ |
| 2015-2017 | 21.0%  | 7.9%   | -8.0%  | 0.0   | 215.0  |
| 2016-2018 | 9.0%   | 67.3%  | -6.0%  | 0.1   | 215.1  |
| 2017-2019 | 24.0%  | 70.4%  | 2.0%   | 0.3   | 292.3  |
| 2018-2020 | 27.0%  | 78.8%  | 4.0%   | 0.4   | 325.7  |
| 2019-2021 | 41.0%  | 78.8%  | -5.0%  | 0.5   | 382.9  |
| 2020-2022 | 13.0%  | 79.4%  | 13.0%  | 0.6   | 354.7  |
| 2021-2023 | 26.0%  | 79.4%  | 24.0%  | 0.4   | 343.0  |
| 2022-2024 | 9.0%   | 79.4%  | -12.0% | 0.4   | 392.4  |
| 2023-2025 | -18.0% | 80.1%  | -85.0% | 0.1   | 338.8  |

*   **CAGR:** Fluctuates significantly year to year, and most recently is negative.
*   **MDD:**  Maximum Drawdown is generally high, showing large volatility and risk.
*   **Alpha:**  Indicates performance relative to a benchmark (likely the S&P 500).  A negative alpha, particularly the large negative values recently, confirms the underperformance relative to the market.
*   **Beta:**  Measures volatility relative to the market.  PG's beta is relatively low (mostly below 0.5), indicating it's less volatile than the overall market.
*   **Cap(B):** Market Capitalization in Billions. The Market Capitalization fluctuated but in the latest year it is at its lowest.

**2) Recent Stock Price Fluctuations:**

*   **Current Close:** 144.74
*   **Previous Close:** 144.49
*   **Change:** 0.17
*   **5-day SMA:** 143.91
*   **20-day SMA:** 143.93
*   **60-day SMA:** 147.43

*   **Analysis:** The current price is slightly above the 5-day and 20-day Simple Moving Averages, suggesting a slight upward trend in the very short term. However, the price is below the 60-day SMA, indicating a potential longer-term downtrend or consolidation.

**3) Indicators Analysis:**

*   **MRI (Market Risk Indicator):** 1.0 (High Investment Recommended) - While indicating generally safety, this contradicts other findings.
*   **RSI (Relative Strength Index):** 52.97 - Neutral. Not overbought or oversold.
*   **PPO (Percentage Price Oscillator):** 0.21 -  Indicates slight positive momentum.
*   **Hybrid Signal:** "cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00)" -  Recommends a full investment.
*   **Recent (20 days) relative divergence change:** 1.0 (+): 단기상승 (Short-term rise) - Suggests recent improvement relative to the S&P 500.
*   **Price Change:** The provided data suggests the price change from the previous close is not a significant fluctuation.
*   **Expected Return (%):** -0.5% - Projects slight negative returns over the long term, underperforming the S&P 500.

**4) Recent News & Significant Events:**

*   **Key Themes from Headlines:**
    *   **Price Pullback:** Multiple articles discuss a recent pullback in PG's share price.
    *   **Value Opportunity?:** Some articles question if the pullback represents a value opportunity.
    *   **Analyst Downgrades:** Meyer Handelman Co. Cuts Holdings in Procter & Gamble Company.
    *   **Two-Year Low:** At least one article mentions PG stock hitting a two-year low.
*   **Analysis:** The news sentiment appears mixed to slightly negative. The price pullback is a recurring theme, and while some sources suggest a potential value play, others highlight concerns.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy
*   **Mean Rating:** 1.92 (~Buy)
*   **Opinions:** 22
*   **Target Price (avg/high/low):** 168.95 / 186.00 / 148.00
*   **Recent Rating Changes:**  No data provided

*   **Analysis:**  The analyst consensus remains positive with a "Buy" rating and a mean rating suggesting a generally favorable outlook. The average target price suggests a potential upside from the current price. The lack of specific data on recent rating changes makes it difficult to assess any recent shifts in analyst sentiment.

**5) Recent Earnings Analysis:**

| 날짜       | EPS  | 매출        |
| ---------- | ---- | ----------- |
| 2025-10-24 | 2    | 22.39 B$    |
| 2025-04-24 | 1.58 | 19.78 B$    |
| 2025-01-22 | 1.94 | 21.88 B$    |
| 2024-10-18 | 1.65 | 21.74 B$    |
| 2025-10-24 | 1.65 | 21.74 B$    |

*   **Analysis:** Revenue has fluctuated, with the most recent quarter showing a strong number. EPS has also fluctuated. Overall, the recent trend is mixed.

**6) Financial Information (Revenue & Profitability, Capital & Profitability):**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
| ------------ | ---------- | --------------- |
| 2025-09-30   | $22.39B   | 51.37%          |
| 2025-06-30   | $20.89B   | 49.11%          |
| 2025-03-31   | $19.78B   | 50.98%          |
| 2024-12-31   | $21.88B   | 52.39%          |
| 2024-09-30   | $21.74B   | 52.06%          |

**Capital and Profitability:**

| Quarter      | Equity     | ROE   |
| ------------ | ---------- | ----- |
| 2025-09-30   | $53.27B   | 8.92% |
| 2025-06-30   | $52.01B   | 6.95% |
| 2025-03-31   | $52.27B   | 7.21% |
| 2024-12-31   | $51.17B   | 9.05% |
| 2024-09-30   | $51.84B   | 7.64% |

*   **Analysis:**
    *   **Revenue:** Shows some variability, with the latest quarter being strong.
    *   **Profit Margin:** Relatively stable, hovering around 50-52%, indicating good cost management.
    *   **Equity:** Gradually increasing, suggesting retained earnings are building up.
    *   **ROE (Return on Equity):** Also varies, but generally healthy, indicating good profitability relative to shareholders' equity.

**7) Comprehensive Analysis (Summary):**

*   **Underperformance:** PG has significantly underperformed the S&P 500, as indicated by the large negative divergence.
*   **Mixed Signals:** Technical indicators present a mixed picture. Short-term moving averages suggest a slight upward trend, but the 60-day SMA suggests a possible downtrend. The RSI is neutral, while the PPO indicates slight positive momentum.
*   **Negative Outlook, contradicted:** While MRI suggest a very safe play, the long-term expected return is slightly negative and Alpha indicates negative long term performance.
*   **Recent Challenges:** News headlines highlight a recent price pullback and raise questions about whether PG is a value opportunity. Analyst downgrade is happening.
*   **Financial Stability:** Despite the stock's recent struggles, PG's financials appear solid. Revenue is reasonably consistent, profit margins are healthy, and ROE is generally good.
*   **Analyst Optimism, but conflicting signals:** Despite the struggles of the stock, Analyst are still indicating a positive recommendation.

**Conclusion:**

PG presents a complex picture. While the company demonstrates financial stability and analysts maintain a positive outlook, the stock has significantly underperformed the market, and recent news highlights concerns about a price pullback. Investors need to carefully weigh the potential risks and rewards before investing in PG. Further investigation into the reasons behind the underperformance, the drivers of the recent price pullback, and the specific factors analysts are considering in their "Buy" recommendations would be prudent.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.